TY - JOUR
T1 - Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide
AU - Alonso-Galicia, Magdalena
AU - Drummond, Heather A.
AU - Kishta Reddy, K.
AU - Falck, J R
AU - Roman, Richard J.
PY - 1997/1
Y1 - 1997/1
N2 - Nitric oxide (NO) inhibits a variety of heme-containing enzymes, including NO synthase and cytochrome P4501A1 and 2B1. The present study examined whether NO inhibits the production of 20-hydroxyeicosatetraenoic acid (20-HETE) by cytochrome P4504A enzymes and whether blockade of the production of this substance contributes to the vascular effects of NO. Sodium nitroprusside (SNP; 10-5, 10-4, and 10-3 mol/L) reduced the production of 20-HETE by renal microsomes incubated with arachidonic acid to 71±5%, 29±4%, and 4±2% of control, respectively (n=5). Similar results were obtained with the use of 1-propanamine, 3-(2-hydroxy-2-nitroso-1- propylhydrazino) (n=3). To determine whether inhibition of 20-HETE contributes to the vasodilatory effects of NO, the effects of dibromo- dodecenylmethylsulfimide (DDMS), a selective inhibitor of the formation of 20-HETE, on the response to SNP (10-7 to 10-3 mol/L) were examined in rat renal arterioles preconstricted with phenylephrine (n=5). SNP increased vascular diameter in a concentration-dependent manner to 82±4% of control. After DDMS (25 μmol/L), SNP (10-3 mol/L) increased vascular diameter by only 17±3%. The effects of DDMS on the mean arterial pressure (MAP) and renal blood flow (RBF) responses to infusion of an NO donor and a synthase inhibitor were also examined in thiobutabarbital-anesthetized, Sprague- Dawley rats. Infusion of MAHMA NONOate at 1, 3, 5, and 10 nmol/min reduced MAP by 16±2, 30±3, 40±5, and 48±5 mm Hg and lowered renal vascular resistance (RVR) by 15±3%, 26±2%, 30±3%, and 34±4% of control. After DDMS (10 mg/kg, n=7 rats), the MAP and RVR responses to 1-hexamine, 6-(2-hydroxy- 1-methyl-2-nitrohydrazino)N-methyl (MAHMA NONOate) averaged only 20% of those seen during control. In other experiments. MAP increased by 32±4% and RBF fell to 56±5% of control after administration of N-nitro-L-arginine (L- NArg) (10 mg/kg IV). After DDMS (10 mg/kg, n=7 rats). MAP increased by only 19±4% and RBF fell by only 7±4% after L-NArg. These results indicate that NO inhibits cytochrome P4504A enzymes and that inhibition of the production of 20-HETE contributes to the vasodilatory effects of NO.
AB - Nitric oxide (NO) inhibits a variety of heme-containing enzymes, including NO synthase and cytochrome P4501A1 and 2B1. The present study examined whether NO inhibits the production of 20-hydroxyeicosatetraenoic acid (20-HETE) by cytochrome P4504A enzymes and whether blockade of the production of this substance contributes to the vascular effects of NO. Sodium nitroprusside (SNP; 10-5, 10-4, and 10-3 mol/L) reduced the production of 20-HETE by renal microsomes incubated with arachidonic acid to 71±5%, 29±4%, and 4±2% of control, respectively (n=5). Similar results were obtained with the use of 1-propanamine, 3-(2-hydroxy-2-nitroso-1- propylhydrazino) (n=3). To determine whether inhibition of 20-HETE contributes to the vasodilatory effects of NO, the effects of dibromo- dodecenylmethylsulfimide (DDMS), a selective inhibitor of the formation of 20-HETE, on the response to SNP (10-7 to 10-3 mol/L) were examined in rat renal arterioles preconstricted with phenylephrine (n=5). SNP increased vascular diameter in a concentration-dependent manner to 82±4% of control. After DDMS (25 μmol/L), SNP (10-3 mol/L) increased vascular diameter by only 17±3%. The effects of DDMS on the mean arterial pressure (MAP) and renal blood flow (RBF) responses to infusion of an NO donor and a synthase inhibitor were also examined in thiobutabarbital-anesthetized, Sprague- Dawley rats. Infusion of MAHMA NONOate at 1, 3, 5, and 10 nmol/min reduced MAP by 16±2, 30±3, 40±5, and 48±5 mm Hg and lowered renal vascular resistance (RVR) by 15±3%, 26±2%, 30±3%, and 34±4% of control. After DDMS (10 mg/kg, n=7 rats), the MAP and RVR responses to 1-hexamine, 6-(2-hydroxy- 1-methyl-2-nitrohydrazino)N-methyl (MAHMA NONOate) averaged only 20% of those seen during control. In other experiments. MAP increased by 32±4% and RBF fell to 56±5% of control after administration of N-nitro-L-arginine (L- NArg) (10 mg/kg IV). After DDMS (10 mg/kg, n=7 rats). MAP increased by only 19±4% and RBF fell by only 7±4% after L-NArg. These results indicate that NO inhibits cytochrome P4504A enzymes and that inhibition of the production of 20-HETE contributes to the vasodilatory effects of NO.
KW - enzymes
KW - nitric oxide
KW - vasculature
UR - http://www.scopus.com/inward/record.url?scp=0031017358&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031017358&partnerID=8YFLogxK
U2 - 10.1161/01.hyp.29.1.320
DO - 10.1161/01.hyp.29.1.320
M3 - Article
C2 - 9039122
AN - SCOPUS:0031017358
SN - 0194-911X
VL - 29
SP - 320
EP - 325
JO - Hypertension
JF - Hypertension
IS - 1 II
ER -